Key Questions RAS Can Help You Answer
What is the current solid tumor clinical development landscape?
What are the key market impacting events?
What´s the strategy of major Oncology players?
What´s the positioning and strategy for a molecule of interest?
What are the upcoming innovation waves? What are the opportunities created by them?
What´s the current state-of-the-art in cancer biomarkers?
How to keep pace with the regulatory policies & payer positions across geographies?
What drug candidates/ companies are suitable for partnering or in-licensing for oncology therapeutics?